How
Hairitige
works
Rejuvenate the look of your hair with a non-invasive, cosmetic scalp wellness system.
Minimal Treatments
Hairitige Service Plans
Targeted service plans limit the need for daily routines and make the hair appearance journey simple.
No Daily Applications
Simple, Single-Session Services
Gone are the days of sticky creams and rigorous daily applications. Visible improvement after just one service session.
No Downtime
Same Day Services
Get back to your normal life immediately after a service session. Hairitige's exosome-based formula and non-invasive applications make every session a breeze.
Explore the benefits of Hairitige's select compounds and how they strengthen our process.
01 Stem Cell Exosomes
Cosmetic ingredient that supports the appearance of a rejuvenated scalp
Prolong rejuvenation
Designed for topical scalp application
02 Copper Peptides
Cosmetic copper peptide formulation
Supports the appearance of fuller, healthier-looking hair
Designed for topical scalp application
Part of the Hairitige cosmetic system
03 Application Methods
Non-surgical cosmetic applications
JuvaSonic© cosmetic application device
Customizable topical serums
Real results via custom-tailored exosome-based formulas, catered to your specific hair appearance goals. Tracked and measured by AI progress metrics for visible hair & scalp rejuvenation.
- How We Track Growth
The Hairitige system measures hair appearance and scalp wellness the way wellness should - with numbers. Three patent-pending metrics tracked across seven defined zones.
- Section 1
The 7-Zone
Scalp Map
Every patient is imaged across seven defined regions. Zone 7 — the posterior occipital — serves as the genetically protected baseline against which all other zones are measured.
- Section 2
Hairitige
Ratio Score™
Density of target zone divided by the density of occipital baseline
Your occipital baseline (Zone 7) is genetically protected from common patterned loss. By dividing each target zone's density by that baseline, we get a stable ratio that strips out lighting, technician, and even patient-to-patient variability. An HRS of 1.0 means a zone is performing at your own personal best. Anything below 1.0 quantifies exactly how much regrowth potential remains.
- Section 3
Hairitige
Scalp Health Ratio™
Healthy scalp, healthy growth. HSHR measures the substrate.
Density alone tells half the story. HSHR captures the inflammatory, sebaceous, and microbial state of the scalp itself and ratios it against an established healthy benchmark. Two patients can have identical HRS values and very different HSHRs — and very different growth trajectories.
- Section 4
Composite Health Index
One number that captures the whole scalp.
The CHI is the single number that summarizes both ratios across all seven zones, with clinically tuned weights for each region. It's the metric we track from baseline through year two. If only one number followed you through your treatment journey, this would be it. Two patients can have identical HRS values and very different HSHRs — and very different growth trajectories.
- Section 5
The Hairitige Treatment Timeline
Every patient is imaged on the same cadence — from baseline through year two.
Day 0
Baseline Imaging
Day 30
First Check-In
Day 60
Trajectory Review
Day 90
Initial CHI Delta
Day 180
Mid-Program Audit
1-2 Year
Long Term Tracking
- How We Track Growth
Verified Results with AI Follicle and Treatment Tracking
Powered by Gro Technologies
What does GroTrack do?
GroTrack utilizes AI-driven follicle detection and growth metrics to scientifically measure treatment success.
How does GroTrack help?
Gallery of high-resolution before and after images overlapped to show comparisons
A custom hair analysis report
Charts and graphs demonstrating hair growth
Hairitige benefits
GroTrack gives the answers needed early in your treatment program since thinning hair improvement is often not visible with a naked eye or in photos during the first months.
See how we use GroTrack to monitor patient's progress and rejuvenation points across many metrics
- How We Apply Treatments
Trusted Application Methods
Hairitige services utilize Juvasonic©, a revolutionary handheld FDA-registered Class I cosmetic device designed to enhance topical absorption of our proprietary exosome and copper peptide formulations.
With precision-engineered, microchannel vibration, microdermabrasion and dual-wavelength light support. Needle free, no downtime and no pain.
See game-changing results with limited sessions
Start your rejuvenation journey and rejuvenate your hair today
Supporting Scientific Findings and Exisiting Research
Exosomes and Follicle Health
- Studies using animal models and at the cellular level have shown that exosomes promote hair growth
- Exosome therapy stands out from cell therapy due to its low immunogenicity and fewer adverse reactions.
- It is envisioned that this novel exosomal therapy will eventually become a novel and hopeful choice for treating alopecia.
Read More at PubMed Central:
© 2024 Cheng et al. Cheng M, Ma C, Chen HD, Wu Y, Xu XG. The Roles of Exosomes in Regulating Hair Follicle Growth. Clin Cosmet Investig Dermatol. 2024 Jul 5;17:1603-1612. doi: 10.2147/CCID.S465963. PMID: 38984321; PMCID: PMC11232880.
Molecular Insights into Hair Regeneration
- Leveraging molecular insights can lead us toward yielding novel strategies to promote hair growth
Read More at PubMed Central:
Sung JH. Special Issue "Molecular Insights into Hair Regeneration". Int J Mol Sci. 2026 Jan 2;27(1):477. doi: 10.3390/ijms27010477. PMID: 41516348; PMCID: PMC12786770.
Exosome-Based Therapies for Alopecia Areata
- Exosome-based therapy may offer a promising and biologically plausible approach for the treatment of alopecia areata
- Preclinical studies consistently demonstrate beneficial effects in both in vitro and animal models, and early clinical reports provide preliminary signals of efficacy
Read More at PubMed Central:
Bulgaru-Iliescu AI, Moraru DC, Amarandei AH, Avadanei-Luca S, Constantinescu MC, Rusu AC, Pertea M. Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence. Int J Mol Sci. 2025 Dec 19;27(1):21. doi: 10.3390/ijms27010021. PMID: 41515899; PMCID: PMC12785886.